Shay Capital’s CollPlant Biotechnologies CLGN Stock Holding History

Shay Capital’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$70.2K	–	438
2023 Q1	$70.2K	Buy	+10,000	New	+$98.2K	0.01%	364

Other funds holding CLGN

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Shay Capital's CLGN Position: Q2 2023 in Review

Shay Capital sold out of CollPlant Biotechnologies (CLGN) in Q2 2023, closing a stake of 10,000 shares — an estimated $70.2K sold.

Shay Capital first reported a position in CLGN in Q1 2023 and held it in 1 quarter. The position peaked at $70.2K in Q1 2023. 17 funds tracked by Wall St. Rank hold CLGN as of Q2 2023.

Shay Capital reported no remaining CollPlant Biotechnologies position as of Q2 2023 after selling out during the quarter.
Shay Capital sold 10,000 CollPlant Biotechnologies shares in Q2 2023, an estimated $70.2K.
Shay Capital first reported a position in CollPlant Biotechnologies in Q1 2023 and held it in 1 quarter.
Shay Capital's CollPlant Biotechnologies position peaked at $70.2K in Q1 2023.
17 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2023.

Based on Shay Capital's 13F filing for Q2 2023, filed 14 Aug 2023.